HSBC HOLDINGS PLC

Position in ALXO — Alx Oncology Holdings Inc

CIK 873630 LONDON, X0

Position in ALXO

as of Mar 31, 2026 · filed Apr 30, 2026 Compact

Position Value

$20,260

+$8,842 QoQ

Shares Held

10,105

0.0% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#55

of 68 holders

Holding Since

Sep 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HSBC HOLDINGS PLC holds $964,220,373 across 121 Biotechnology names. ALXO ranks #119 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	655,443	$292,681,510
2	REGN	Regeneron Pharmaceuticals, Inc.	323,338	$249,823,869
3	RPRX	Royalty Pharma plc	1,544,018	$74,066,541
4	INCY	Incyte Corp	582,368	$54,812,474
5	ALNY	Alnylam Pharmaceuticals, Inc.	89,619	$29,652,235
6	MRNA	Moderna, Inc.	490,088	$24,896,468
7	INSM	INSMED Inc	116,456	$19,042,883
8	PTCT	Ptc Therapeutics, Inc.	227,059	$15,469,528

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$20,260	10,105	0.0%	Shares	Defined	2026-04-30
2025-12-31	$11,418	10,105	-6.6%	Shares	Defined	2026-03-20
2025-09-30	$19,795	10,817	-12.1%	Shares	Defined	2025-11-13
2025-06-30	$5,106	12,306	-23.7%	Shares	Defined	2025-08-13
2025-03-31	$10,047	16,128	-0.2%	Shares	Defined	2025-05-14
2024-12-31	$26,977	16,154	+16.1%	Shares	Defined	2025-02-14
2024-09-30	$25,332	13,919	+29.1%	Shares	Defined	2024-11-14
2024-06-30	$65,003	10,780	-39.4%	Shares	Defined	2024-08-12
2023-12-31	$264,937	17,793	-49.7%	Shares	Defined	2024-02-12
2023-09-30	$169,939	35,404	—	Shares	Defined	2023-11-13
No filing history on record for this holder in this stock.